Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors
Colombo S, Ferrari A, Meiser W, Janson N, Roscilli G, Sewald N (2022)
In: Journal of Peptide Science ., 28(S3). Hoboken: Wiley.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Colombo, SvevaUniBi;
Ferrari, AnaUniBi;
Meiser, WaldemarUniBi;
Janson, NilsUniBi;
Roscilli, Giuseppe;
Sewald, NorbertUniBi 
Einrichtung
Erscheinungsjahr
2022
Titel des Konferenzbandes
Journal of Peptide Science
Band
28
Ausgabe
S3
Art.-Nr.
P255
Konferenz
36th European Peptide Symposium, 12th International Peptide Symposium
Konferenzort
Sitges, Barcelona
Konferenzdatum
2022-08-28 – 2022-09-02
ISSN
1075-2617
eISSN
1099-1387
Page URI
https://pub.uni-bielefeld.de/record/2980257
Zitieren
Colombo S, Ferrari A, Meiser W, Janson N, Roscilli G, Sewald N. Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors. In: Journal of Peptide Science . Vol 28. Hoboken: Wiley; 2022.
Colombo, S., Ferrari, A., Meiser, W., Janson, N., Roscilli, G., & Sewald, N. (2022). Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors. Journal of Peptide Science , 28 Hoboken: Wiley.
Colombo, Sveva, Ferrari, Ana, Meiser, Waldemar, Janson, Nils, Roscilli, Giuseppe, and Sewald, Norbert. 2022. “Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors”. In Journal of Peptide Science . Vol. 28. Hoboken: Wiley: P255.
Colombo, S., Ferrari, A., Meiser, W., Janson, N., Roscilli, G., and Sewald, N. (2022). “Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors” in Journal of Peptide Science , vol. 28, (Hoboken: Wiley).
Colombo, S., et al., 2022. Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors. In Journal of Peptide Science . no.28 Hoboken: Wiley.
S. Colombo, et al., “Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors”, Journal of Peptide Science , vol. 28, Hoboken: Wiley, 2022.
Colombo, S., Ferrari, A., Meiser, W., Janson, N., Roscilli, G., Sewald, N.: Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors. Journal of Peptide Science . 28, Wiley, Hoboken (2022).
Colombo, Sveva, Ferrari, Ana, Meiser, Waldemar, Janson, Nils, Roscilli, Giuseppe, and Sewald, Norbert. “Novel Antibody-Drug Conjugates (ADCs) of thiol-based suberoylanilide hydroxamic acid (SAHA) histone deacetylase (HDAC) inhibitors”. Journal of Peptide Science . Hoboken: Wiley, 2022.Vol. 28.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar